Categories: aggregated

Pharmaceutical Companies Win Big with Schedule 3 Classification of Cannabis – Desheduling is the Only Way for True Equity

For decades, Joe Biden has been cozy with Big Pharma, accepting millions in campaign contributions from drug companies over his long political career. It’s no secret that the pharmaceutical industry vehemently opposes cannabis legalization, as legal weed represents a major threat to their profits from opiate painkillers and other drugs. Pharma much prefers that cannabis remain illegal, or barring that, placed into a restrictive category like Schedule III that they can control and corner the market on.

Jason

Share
Published by
Jason

Recent Posts

If You Can Keep a Cannabis Mother Plant Alive, You Can Bake Sourdough

Cannabis grower and edibles pioneer Maya Elisabeth makes the case that your sourdough starter is…

2 hours ago

You’ve Got Mail: Are Berlin Drug Dealers Really Leaving Free Samples in Mailboxes?

Berlin police are warning residents after receiving reports that suspected drug samples were being left…

2 hours ago

Cannabis Culture Needs Collaboration, Not Fragmentation

Cannabis culture survived through decentralized human connection. Its future depends on whether the people building…

2 hours ago

The Entourage Effect Isn’t One Thing: What a New Receptor Study Actually Found

For years, the cannabis world has treated "the entourage effect" like settled science, a comforting…

2 hours ago

Five Years and $100,000 Later, New York Finally Let Me Sell Weed

After five years, two applications, six figures in expenses, and a maze of shifting rules,…

2 days ago